Ansari Khalid, Keaney Niall, Kay Andrea, Price Monica, Munby Joan, Billett Andrew, Haggerty Sharon, Taylor Ian K, Al Otaibi Hajed
Department of Respiratory Care, College of Applied Medical Sciences, University of Dammam, Dammam, Kingdom of Saudi Arabia; Chest Clinic, Sunderland Royal Hospital, Sunderland, UK.
Chest Clinic, Sunderland Royal Hospital, Sunderland, UK.
Ann Thorac Med. 2016 Oct-Dec;11(4):261-268. doi: 10.4103/1817-1737.191866.
The assessment of the severity of chronic obstructive pulmonary disease (COPD) should involve a multidimensional approach that is now clearly shown to be better than using spirometric impairment alone. The aim of this study is to validate and compare novel tools without an exercise test and to extend prognostic value to patients with less severe impairment of Forced expiratory volume 1 s.
A prospective, observational, primary care cohort study identified 458 eligible patients recruited from the primary care clinics in the northeast of England in 1999-2002. A new prognostic indicator - body mass index, airflow obstruction and dyspnea (BOD) together with the conventional prognostic indices age, dyspnea and airflow obstruction (ADO), global initiative for chronic obstructive lung disease (GOLD) and new GOLD matrix were studied. We also sought to improve prognostication of BOD by adding age (A) and smoking history as pack years (S) to validate BODS (BOD with smoking history) and BODAS (BOD with smoking history and age) as prognostic tools and the predictive power of each was analyzed.
The survival of the 458 patients was assessed after a median of 10 years when the mortality was found to be 33.6%. The novel indices BOD, BODS, and BODAS were significantly predictive for all-cause mortality in our cohort. Furthermore with ROC analysis the C statistics for BOD, BODS, and BODAS were 0.62, 0.66, and 0.72, respectively ( < 0.001 for each), whereas ADO and GOLD stages had a C statistic of 0.70 ( < 0.001) and 0.56 ( < 0.02), respectively. GOLD Matrix was not significant in this cohort.
BOD, BODS, and BODAS scores are validated predictors of all-cause mortality in a primary care cohort with COPD.
慢性阻塞性肺疾病(COPD)严重程度的评估应采用多维度方法,现已明确显示这种方法优于仅使用肺量计测定的损伤情况。本研究的目的是验证和比较无需运动试验的新型工具,并将预后价值扩展至第一秒用力呼气量损伤较轻的患者。
一项前瞻性、观察性、初级保健队列研究纳入了1999年至2002年从英格兰东北部初级保健诊所招募的458例符合条件的患者。研究了一种新的预后指标——体重指数、气流阻塞和呼吸困难(BOD),以及传统的预后指标年龄、呼吸困难和气流阻塞(ADO)、慢性阻塞性肺疾病全球倡议(GOLD)和新的GOLD矩阵。我们还试图通过加入年龄(A)和以包年计算的吸烟史(S)来改善BOD的预后评估,以验证BODS(有吸烟史的BOD)和BODAS(有吸烟史和年龄的BOD)作为预后工具,并分析了各自的预测能力。
在中位时间10年后评估了458例患者的生存情况,发现死亡率为33.6%。新型指标BOD、BODS和BODAS对我们队列中的全因死亡率具有显著预测性。此外,通过ROC分析,BOD、BODS和BODAS的C统计量分别为0.62、0.66和0.72(均P<0.001),而ADO和GOLD分期的C统计量分别为0.70(P<0.001)和0.56(P<0.02)。GOLD矩阵在该队列中无显著意义。
BOD、BODS和BODAS评分是COPD初级保健队列中全因死亡率的有效预测指标。